$MLTX
MoonLake Immunotherapeutics
Nasdaq · Healthcare · Pharmaceutical Preparations · Zug, Switzerland
MLTX chart
What traders are saying about $MLTX
Latest postsMoonLake Immunotherapeutics news
- How Investors May Respond To MoonLake Immunotherapeutics Stock As Sonelokimab Nears FDA Filing
Simply Wall Street ·
- MoonLake Immunotherapeutics (MLTX) Rides HS Narrative Following Rebound As Undervalued View Holds
Yahoo Finance ·
- MoonLake Immunotherapeutics (MLTX) Dropped, What Is Driving Attention Now?
Simply Wall Street ·
- MoonLake Immunotherapeutics (MLTX) Stock Trades Above Fair Value On Balance Sheet Questions
Yahoo Finance ·
- MoonLake Immunotherapeutics Estimates – NASDAQ:MLTX
TradingView ·
- MoonLake Immunotherapeutics (MLTXN.MX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- AbbVie Slips Behind Rivals as Lutikizumab Hits 31.4% Response in HS Trial
tikr.com ·
- What's Going On with MoonLake Immunotherapeutics Stock on Thursday?
TradingView ·
- MoonLake Soars 18% as Rival AbbVie’s Skin Disease Trial Data “Underwhelms”
tikr.com ·
- Why Are Amaero, Healthcare Services Group, Badger Meter, MoonLake Immunotherapeutics, America's Car-Mart, Full House Resorts, Tucows and Biohaven Rallying Hard, and Is an Actual Catalyst Driving Each Jump?
kalkine.ca ·
- What Is Powering the Rally in Karyopharm Therapeutics, Estrella Immunopharma, CytoSorbents, MoonLake Immunotherapeutics, FibroBiologics, Exicure, Biohaven and Profusa Stocks Today, and What Should Investors Know About the Catalysts?
kalkine.ca ·
- MoonLake Immunotherapeutics Makes Case for Sonelokimab Approval, RBC Says
Yahoo Finance ·
MoonLake Immunotherapeutics key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$227.3M | -$118.9M | -$36.0M | -$50.0M |
| Diluted EPS | $-3.53 | $-1.89 | $-0.73 | $-1.70 |
| Total assets (year end) | $424.4M | $477.9M | $526.5M | $76.8M |
| Cash and equivalents (year end) | $334.5M | $180.4M | $451.2M | $39.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KCURRENT REPORT
- 10-Q10-Q
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-Q10-Q
- 8-K8-K
- DEF 14ADEF 14A
- 10-K10-K
About MoonLake Immunotherapeutics
- Ticker
- MLTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Zug, Switzerland
- Incorporated in
- Cayman Islands
- Fiscal year end
- December 31
- SEC CIK
- 1821586
- Former names
- Helix Acquisition Corp
Frequently asked questions
What exchange is MoonLake Immunotherapeutics listed on?
MoonLake Immunotherapeutics trades on the Nasdaq under the ticker symbol MLTX.
What industry is MoonLake Immunotherapeutics in?
MoonLake Immunotherapeutics is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is MoonLake Immunotherapeutics headquartered?
MoonLake Immunotherapeutics's business address on file with the SEC is in Zug, Switzerland.
When does MoonLake Immunotherapeutics's fiscal year end?
MoonLake Immunotherapeutics's fiscal year ends on December 31.